PKI Stock Recent News
PKI LATEST HEADLINES
PerkinElmer (PKI) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $2.41 per share a year ago.
Revvity (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.
PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PerkinElmer (PKI) completes separation of its businesses into two entities ??? the AES business, and the Life Sciences and Diagnostics business.
PerkinElmer's (PKI) latest launch is expected to provide increased assay flexibility to researchers.
PerkinElmer's (PKI) fourth-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, more than offset by lower COVID-related sales.
PerkinElmer, Inc. (NYSE:PKI ) Q4 2022 Earnings Conference Call February 14, 2023 8:00 AM ET Company Participants Steve Willoughby - SVP, IR Prahlad Singh - President and CEO Max Krakowiak - SVP and CFO Conference Call Participants Derik de Bruin - Bank of America Patrick Donnelly - Citi Joshua Waldman - Cleveland Research Liza Garcia - UBS Dan Arias - Stifel Jack Meehan - Nephron Research Paul Knight - KeyBanc Max Masucci - Cowen Dan Leonard - Credit Suisse Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Vijay Kumar - Evercore ISI Operator Hello, and welcome to the PerkinElmer Fourth Quarter 2022 Earnings Conference Call. My name is Alex, and I'll be coordinating the call today.
PerkinElmer (PKI) delivered earnings and revenue surprises of 2.41% and 1.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
PerkinElmer continues to offer long-term upside potential with its management of capital and acquisitions. The economic value of its transactions has created a healthy return on investment over the time period.